Genome-wide association study identifies genetic loci associated with body mass index and high density lipoprotein-cholesterol levels during psychopharmacological treatment — a cross-sectional naturalistic study-Reference-Cited by-同舟云学术

Genome-wide association study identifies genetic loci associated with body mass index and high density lipoprotein-cholesterol levels during psychopharmacological treatment — a cross-sectional naturalistic study

Published:2012-05 Issue:3 Volume:197 Page:327-336
ISSN:0165-1781
Container-title:Psychiatry Research
language:en
Short-container-title:Psychiatry Research

Author:

Athanasiu Lavinia,Brown Andrew A.,Birkenaes Astrid B.,Mattingsdal Morten,Agartz Ingrid,Melle Ingrid,Steen Vidar M.,Andreassen Ole A.,Djurovic Srdjan

Funder

Research Council of Norway

South-Eastern and Western Norway Health Authority

Oslo University Hospital Ullevål

University of Oslo

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference45 articles.

1. Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs;Adkins;Molecular Psychiatry,2010

2. Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus;Andersohn;The American Journal of Psychiatry,2009

3. Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort;Athanasiu;Journal of Psychiatric Research,2010

4. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts;Aulchenko;Nature Genetics,2009

5. Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions;Birkenaes;Journal of Clinical Psychopharmacology,2008

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalized and precision medicine as informants for treatment management of bipolar disorder;International Clinical Psychopharmacology;2019-07

2. Fine-mapping of antipsychotic response genome-wide association studies reveals novel regulatory mechanisms;Pharmacogenomics;2017-01

3. The Role of Pharmacogenetics in Pharmacovigilance of Psychotropic Drugs;Pharmacovigilance in Psychiatry;2015-12-08

4. Genome-wide association study identifies common variants associated with pharmacokinetics of psychotropic drugs;Journal of Psychopharmacology;2015-05-05

5. Cardiovascular Toxicity as a Result of Psychotropic Drugs;Heart and Toxins;2015